Agenda: Life Sciences Patent Network North America

Tuesday, October 16, 2018
8:00 AM - 8:30 AM	Registration, welcome coffee and networking
8:30 AM - 8:40 AM	Chairman's Opening Address Eldora Ellison, Partner, Sterne Kessler
8:40 AM - 9:10 AM	Keynote Address: US Patent Enforceability Outlook Eldora Ellison, Partner, Sterne Kessler
9:10 AM - 9:30 AM	Patent Rights in Canada - an update on recent developments New linkage regime for pharmaceuticals/biologics - for better or worse Securing supplementary protection in Canada Regulatory changes to pricing of patented medicines Yoon Kang, Partner, Smart & Biggar Daphne Lainson, Partner, Smart & Biggar
9:30 AM - 10:00 AM	Panel Discussion: How do we Ensure Effective Protection for Antibodies? Moderator: Brian Gummow, Counsel, Hailey & Guiliano Panellists: Glyn Truscott, Partner - UK & European Patent Attorney, Elkington & Fife Atabak Royaee, Associate Director & Senior Counsel, Boehringer Ingelheim Pharmaceuticals Stephanie Yonker, Vice President of Legal, Alector Kathy Coulter, Senior IP Counsel, Bristol-Myers Squibb
10:00 AM - 10:30 AM	Panel Discussion: IP Considerations in Personalised Medicine Moderator: Filko Prugo, Partner & Chair, Life Sciences IP Litigation, Ropes & Gray Panellists: Jason Christiansen, Senior Director, Assistant General Counsel, IP, Adamas Pharmaceuticals John Sninsky, Chief Scientific Officer, CareDx Aruna Gambhir, Chief Executive Officer, CellSight Technologies
10:30 AM - 10:50 AM	Evidence Collection Procedure and Protection of Confidential Information in Patent Litigation in Japan The rise of unbranded generics: What does the future hold? Patent Prosecution Practice in Asia: Jurisdictional Overview Counterfeiting challenges: How can brand owners protect their rights and are global enforcement efforts yielding results? Takanori Abe, Founder & Attorney, Abe & Partners
10:50 AM - 11:20 AM	Morning coffee and networking
11:20 AM - 12:00 PM	Panel Discussion: Focus on Mergers & Acquisitions What’s driving the current high level of M&A? What impact is US tax reform having on M&A activity? Are acquisitions a replacement for innovation – and what’s the impact of that? What should be the key IP Considerations in M&A? Moderator: Peter Scott, Publisher, LSIPR Panellists: Tracy MacNeal, President, XimedicaDx Rebecca Lin, VP of Strategy and Global Business Development, Potrero Medical Joel Harris, Senior Director of IP, Incube Labs
12:00 PM - 12:15 PM	Don’t Rock the Boat, Change is a Frightening Proposition Mitchell Atherton, Global Strategy Director, SHIP Global IP
12:15 PM - 12:45 PM	The Intersection of High-Tech and Life Sciences Patent Law: When Worlds Collide Nathan Zhang, Counsel, Global Litigation and Investigations, Applied Materials
12:45 PM - 1:15 PM	Talking Heads: Updates and Developments in Europe Supplementary Protection Certificates Overview What’s the latest on the Unified Patent Court? Examining Plausibility Host: Peter Scott, Publisher, LSIPR Talking Heads: Joel Coles, Senior Associate, Powell Gilbert Bethan Hopewell, Partner, Powell Gilbert
1:15 PM - 2:00 PM	Lunch and networking
2:00 PM - 2:10 PM	Roundtable Discussion Groups Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 40-45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunity to share knowledge and opinion, and ends with a moderator round-up of key findings, providing delegates with an insight into all eight topics. SESSION 1 - PLEASE CHOOSE YOUR FIRST TABLE FROM THE FOLLOWING:
2:10 PM - 2:50 PM	Considerations When Drafting CRISPR Patent Applications Patrick Morris, Partner, Perkins Coie	How do we Ensure Effective Protection of Antibodies? Yifan Mao, Associate, Kilpatrick Townsend & Stockton	Impact of IPR and PGR Proceedings on Biologics and Biosimilars Brian Gummow, Counsel, Hailey & Guiliano	IP Considerations in Personalised Medicine Jason Christiansen, Senior Director, Assistant General Counsel, Intellectual Property, Adamas Pharmaceuticals	Licensing and Joint Ownership of IP: Practical Strategies Raymond Doss, Senior Counsel, Amgen	Life Sciences Patents Open Table: Solving In-House Counsel Challenges BrianSlater, Partner & Chair of Life Sciences, Kramer Levin	Second Medical Use Opportunities from Personalised Healthcare Inventions in Europe Laurence Gainey, Patent Director, HGF	Strategies in Second Medical Use Cases Filko Prugo, Partner, Ropes & Gray Charlotte Jacobsen, Partner, Ropes & Gray
2:50 PM - 2:55 PM	SESSION 2 - PLEASE CHOOSE YOUR SECOND TABLE FROM THE FOLLOWING:
2:55 PM - 3:40 PM	Considerations When Drafting CRISPR Patent Applications Patrick Morris, Partner, Perkins Coie	How do we Ensure Effective Protection of Antibodies? Yifan Mao, Associate, Kilpatrick Townsend & Stockton	Impact of IPR and PGR Proceedings on Biologics and Biosimilars Brian Gummow, Counsel, Hailey & Guiliano	Licensing and Joint Ownership of IP: Practical Strategies Raymond Doss, Senior Counsel, Amgen	Life Sciences Patents Open Table: Solving In-House Counsel Challenges BrianSlater, Partner & Chair of Life Sciences , Kramer Levin	Strategies in Second Medical Use Cases Filko Prugo, Partner, Ropes & Gray Charlotte Jacobsen, Partner, Ropes & Gray	Second Medical Use Opportunities from Personalised Healthcare Inventions in Europe Laurence Gainey, Patent Director, HGF	IP Considerations in Personalised Medicine Jason Christiansen, Senior Director, Assistant General Counsel, Intellectual Property, Adamas Pharmaceuticals
3:40 PM - 4:00 PM	Discussion group round-up: Key findings and points of note
4:00 PM - 4:30 PM	Afternoon tea and networking
4:30 PM - 4:55 PM	Course Selection and Navigation of Life Sciences Patents in Precision Medicine: a Stakeholder's Perspective Diagnostic technology and content patents are critical elements of precision medicine Recent patent law precedent has fundamentally changed patent strategies and claims Pragmatic consideration of sea changes in patent law inform biomarker commercialization Plans for capitalization and enforcement inform patent strategy John Sninsky, Chief Scientific Officer, CareDx
4:55 PM - 5:20 PM	Recent Advances in Artificial Intelligence in Healthcare John Axerio-Cilies, COO & Founder, Arterys
5:20 PM - 6:00 PM	Panel Discussion: In-house Counsel Share Day-to-Day Challenges in Securing and Protecting Patents Moderator: Eldora Ellison, Partner, Sterne Kessler Panellists: Nada Rastad, General Counsel, 3Scan Robert Bernstein, Intellectual Property Attorney, Plexxikon Aly Fuller, VP, Intellectual Property, Prolacta Bioscience Raymond Doss, Senior Counsel, Amgen
6:00 PM - 7:00 PM	Chair’s Closing Remarks Eldora Ellison, Partner, Sterne Kessler Followed by Networking Drinks Reception

agenda

Contact our team

agenda

Contact our team

Share on social: